Diabetic Kidney Disease: New Promise for Patients Fighting a Stubborn Nemesis? - June 26 @ 1PM EST
Diabetic Kidney Disease: New Promise for Patients Fighting a Stubborn Nemesis?
Event Date: Wednesday, June 26, 2019
Event Time: 1:00–2:00 p.m. Eastern Time
After a nearly-two decade period of inactivity and failed trials in diabetic kidney disease (DKD), recent clinical trials have suggested that a new approach to this complication of diabetes may reduce kidney risk. This presentation will review important epidemiologic aspects of DKD, its natural history and pathophysiology, and current treatment approaches. Finally, we will discuss recent clinical trial advances and preview ongoing large, Phase 3 trial programs.
This webinar is part of a series of educational activities presented by AADE in association with AstraZeneca-US Medical Affairs, CVMD Division. This webinar is educational in nature and contains no promotional or product information. CE credit is not available for this activity.
-- Identify the major factors which drive kidney disease progression in Type 2 Diabetes
-- Identify one new class of agents with potential to improve upon the current standard of care for diabetic kidney disease
This activity is designed for diabetes educators, including RNs, RDs, Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, MDs, and other health care providers interested in staying up to date on current practices of care for their patients with diabetes and other related conditions.
This 60-minute online session includes a presentation followed by a question and answer period.